Indonesia Perpres 6/2023 requires Halal certification for drugs, biological products, and medical devices containing animal-derived materials. BPJPH issues the certificates, while foreign Halal certificates from bodies with an MRA are accepted after registration. Phased compliance is based on risk class: Class A by 2026, B by 2029, C by 2034, and D/biological products by 2039. Non-animal-based devices are exempt unless containing prohibited ingredients, which must be clearly labeled as non-Halal.
Indonesia has introduced Halal certification requirements for medical devices through Peraturan Presiden No. 6 Tahun 2023, which governs halal certification for drugs, biological products, and medical devices.
Under this regulation, medical devices that originate from or contain animal-derived materials must obtain a Halal certificate before they can be marketed in Indonesia. Certification is issued by the Halal Product Assurance Organizing Body (BPJPH) under the Ministry of Religious Affairs.
Products already certified by a Foreign Halal Certification Body (LHLN) with a Mutual Recognition Agreement (MRA) with BPJPH do not require a new certification, but the existing certificate must be registered with BPJPH before marketing.
Devices without animal-derived materials are currently exempt, but any non-Halal ingredients must be labeled accordingly.
The phased implementation allows manufacturers to plan certification processes according to the risk class of their products.
Early planning ensures smooth entry into the Indonesian market and avoids potential regulatory sanctions.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us